ret fusion treatment: pralsetinib - targeted therapies in lung cancer 2023
Published 10 months ago • 83 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
3:49
ret fusion treatment: selpercatinib - targeted therapies in lung cancer 2023
-
7:37
rare fusions in nsclc: ret - targeted therapies in lung cancer 2023
-
6:52
safety and toxicity of selpercatinib versus pralsetinib - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
1:12
q&a: ret fusion, lobectomy, and chemo: risk of recurrence? - targeted therapies in lung cancer 2023
-
2:49
treatments for ret nsclc: selpercatinib vs. pralsetinib - 2022 program: targeted therapies forum
-
8:43
selpercatinib and pralsetinib in ret disease - lung cancer video library
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
2:48
ret fusion-positive mnsclc: selpercatinib and pralsetinib
-
2:21
pralsetinib in chinese patients with advanced ret fusion nsclc
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2
-
3:18
arrow update confirms pralsetinib benefit for ret fusion-positive advanced nsclc | stephen liu
-
6:59
targeted therapy for treatment-naïve ret fusion-positive lung cancers
-
3:56
how to identify ret nsclc - 2022 program: targeted therapies forum
-
7:53
ret nsclc treatment options - 2022 program: targeted therapies forum
-
3:33
grace targeted therapies in lung cancer 2021 - liquid biopsies - tki resistance for alk, ros1 & ret
-
3:32
ret in lung cancer: the next big target?